Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery-Reference-Cited by-同舟云学术

Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery

Published:2013-09-24 Issue:8 Volume:109 Page:2142-2154
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

PosthumaDeBoer J,Piersma S R,Pham T V,van Egmond P W,Knol J C,Cleton-Jansen A M,van Geer M A,van Beusechem V W,Kaspers G J L,van Royen B J,Jiménez C R,Helder M N

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2013578.pdf

Reference55 articles.

1. Abdou AG, Abd el-Wahed MM, Asaad NY, Samaka RM, Abdallaha R (2010) Ephrin A4 expression in osteosarcoma, impact on prognosis, and patient outcome. Indian J Cancer 47: 46–52.

2. Albrethsen J, Knol JC, Piersma SR, Pham TV, de Wit M, Mongera S, Carvalho B, Verheul HM, Fijneman RJ, Meijer GA, Jimenez CR (2010) Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression. Mol Cell Proteomics 9: 988–1005.

3. Altman DG (1991) Practical Statistics for Medical Research. Chapmann & Hall: London.

4. Avnet S, Sciacca L, Salerno M, Gancitano G, Cassarino MF, Longhi A, Zakikhani M, Carboni JM, Gottardis M, Giunti A, Pollak M, Vigneri R, Baldini N (2009) Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. Cancer Res 69: 2443–2452.

5. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jurgens H, Winkler K (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20: 776–790.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the EphA2 pathway: could it be the way for bone sarcomas?;Cell Communication and Signaling;2024-09-09

2. Advances on immunotherapy for osteosarcoma;Molecular Cancer;2024-09-09

3. The EphA2 Receptor Regulates Invasiveness and Drug Sensitivity in Canine and Human Osteosarcoma Cells;Cells;2024-07-16

4. EphA2-specific microvesicles derived from tumor cells facilitate the targeted delivery of chemotherapeutic drugs for osteosarcoma therapy;Journal of Nanobiotechnology;2024-03-03

5. OVERALL REVIEW OF CURATIVE IMPACT AND BARRIERS OF CAR-T CELLS IN OSTEOSARCOMA;EXCLI J;2024